Q1 Earnings Estimate for Repligen Issued By Leerink Partnrs
Repligen Co. (NASDAQ:RGEN – Free Report) – Research analysts at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Repligen in a research note issued on Thursday, February 20th. Leerink Partnrs analyst P. Souda now forecasts that the biotechnology company will earn $0.35 per share for the quarter, down from their […]
Repligen Co. (NASDAQ:RGEN – Free Report) – Research analysts at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Repligen in a research note issued on Thursday, February 20th. Leerink Partnrs analyst P. Souda now forecasts that the biotechnology company will earn $0.35 per share for the quarter, down from their […]
